Merrimack Pharmaceuticals...

NASDAQ: MACK · Real-Time Price · USD
15.14
0.01 (0.07%)
At close: May 17, 2024, 9:59 PM

Merrimack Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
5.99M 19.44M 14.2M
Short-Term Investments
12.89M n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
4K 8K 66K
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
309K 389K 480K
Total Current Assets
19.18M 19.83M 14.68M
Property-Plant & Equipment
n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
4K 8K 66K
Total Assets
19.19M 19.84M 14.75M
Account Payables
74K 188K 120K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
n/a n/a n/a
Other Current Liabilities
367K 401K 442K
Total Current Liabilities
441K 589K 562K
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a
Total Long-Term Liabilities
n/a 589K n/a
Total Liabilities
441K 589K 562K
Total Debt
n/a n/a n/a
Common Stock
1.34M 1.34M 1.33M
Retained Earnings
-548.82M -547.64M -546.09M
Comprehensive Income
n/a -0.00 -0.00
Shareholders Equity
18.75M 19.25M 14.19M
Total Investments
12.89M n/a n/a